NCT06507800View on ClinicalTrials.gov

Cancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease iNdiCation trEated in FRance and Canada?

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions

Autoimmune Diseases

Interventions

OTHER

Observational cohort

Cancer incidence after AHSCT for an autoimmune indication.

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06507800 - Cancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease iNdiCation trEated in FRance and Canada? | Biotech Hunter | Biotech Hunter